Ultragenyx Pharmaceutical (RARE) Assets Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.15% |
| Dec 31, 2025 | -0.29% |
| Sep 30, 2025 | -9.73% |
| Jun 30, 2025 | -0.36% |
| Mar 31, 2025 | -1.77% |
| Dec 31, 2024 | -0.43% |
| Sep 30, 2024 | 1.19% |
| Jun 30, 2024 | 2.28% |
| Mar 31, 2024 | -6.47% |
| Dec 31, 2023 | -5.37% |
| Sep 30, 2023 | -0.80% |
| Mar 31, 2023 | 3.91% |
| Dec 31, 2022 | 10.82% |
| Sep 30, 2022 | 22.52% |
| Jun 30, 2022 | 11.26% |
| Mar 31, 2022 | 11.16% |
| Dec 31, 2021 | 28.38% |
| Sep 30, 2021 | 24.73% |
| Jun 30, 2021 | 23.34% |
| Mar 31, 2021 | 25.04% |
| Dec 31, 2020 | 53.05% |
| Sep 30, 2020 | 42.86% |
| Mar 31, 2020 | 31.22% |
| Dec 31, 2019 | 28.06% |
| Sep 30, 2019 | 19.54% |
| Jun 30, 2019 | 25.77% |
| Mar 31, 2019 | 24.34% |
| Dec 31, 2018 | 8.74% |
| Sep 30, 2018 | 8.31% |
| Jun 30, 2018 | 32.95% |
| Mar 31, 2018 | 31.94% |
| Dec 31, 2017 | 35.34% |
| Sep 30, 2017 | 27.29% |
| Jun 30, 2017 | 45.18% |
| Mar 31, 2017 | 46.75% |
| Dec 31, 2016 | 108.50% |